Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
ASSETS
Cash
Prepaid expenses
Receivable-related party
Receivable
Other current asset - related party
Total current assets
Deferred offering costs
Marketable securities held in Trust Account
Other non-current assets
Total Assets
LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS' DEFICIT
Current liabilities:
Accounts payable
Note payable
Due to related party
Accrued expenses
Total current liabilities
Deferred underwriting fees payable
Derivative warrant liabilities
Total liabilities
Class A ordinary shares subject to possible redemption, $0.0001 par value; 23,000,000 shares at redemption value of $10.58 and $10.35 per share at June 30, 2023 and December 31, 2022, respectively
Common Class A
Total class A ordinary shares subject to possible redemption, $0.0001 par value; 23,000,000 shares at redemption value of $10.58 and $10.35 per share at June 30, 2023 and December 31, 2022, respectively
Shareholders' deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding at June 30, 2023 and December 31, 2022
Common stock value issued
Common Class A
Common Class B
Additional paid-in capital
Accumulated deficit
Total shareholders' deficit
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support